Share

News

Americans riders in a right fix?

French judicial sources have claimed there is enough evidence for them to begin investgations into the use of non-banned but possibly performance enhancing drugs by Lance Armstrong’s US Postal team in this year’s Tour De France.


Allegations concern a “mystery mobile” carrying away medical waste products from the team hotel on a regular basis. What exactly these ‘Scooby snacks’ were has not been confirmed, but the current suspicions revolve around Actovegin a bovine by-product gel designed to restore weak circulatory systems.


US Postal has immeadiately denied the allegations as well as re-confirming their Zero-Tolerance policy on drug taking. This time they have also stated that all medical products they used were inspected and passed by the French medical control agency. The statement also declares that they have not yet been informed of any such formal enquiry.


Meanwhile back home, former US junior team rider Greg Strock is sueing his former coach Rene Wenzel and US cycling for illnesses he has suffered since allegedly being doped while racing with the team on the continent in the early 1990’s. According to Strock, despite his protestations the doping continued until he had to halt his career due to an unknown illness. This was later diagnosed as a Parovirus that has “an 85% correlation with testicular cancer”. Strock himself has no history of the cancer, but it may be significant that testicular cancer survivor and double Tour De France winner Lance Armstrong was a member of the same junior team.


Full versions of both these stories are available on the excellent Velo news website but we’ll bring you the highlights as both cases progress.

Share

Newsletter Terms & Conditions

Please enter your email so we can keep you updated with news, features and the latest offers. If you are not interested you can unsubscribe at any time. We will never sell your data and you'll only get messages from us and our partners whose products and services we think you'll enjoy.

Read our full Privacy Policy as well as Terms & Conditions.

production